A woman’s quality of life—her physical well-being, mood, and appetite—can affect her response to chemotherapy and her overall survival. Researchers surveyed women with advanced breast cancer on details such as pain, nausea and vomiting, and mood; all women were being treated with cyclophosphamide, methotrexate and 5-fluouracil. Those who scored highest on a quality of life scale had higher rates of overall survival. The research was published in the British Journal of Cancer (online, April 13,2010).
Source: Lee, C. K., Stockler, M. R., Coates, A. S., Gebski, V., Lord, S. J. Simes, R. J., 'Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer', British Journal of Cancer , vol. 102, no. 9, 1341-1347 (2010).
No comments:
Post a Comment